Molecular Diagnostics, Antimicrobial Resistance Patterns, and Clinical Outcomes in Hospitalized Pneumonia Patients: A Prospective Study from Jordan and a Call for National Guideline Integration

  19 March 2026

This study of hospitalized pneumonia patients in Jordan shows that molecular diagnostics (PCR) significantly improve pathogen detection compared to traditional cultures, revealing frequent and complex co-infections (including bacterial–viral combinations). Pneumonia outcomes remain severe, with a high mortality rate (27%), and inappropriate (non-guideline) antibiotic use is linked to worse outcomes. The findings also highlight concerning antimicrobial resistance patterns, including high resistance to commonly used antibiotics. Overall, the study underscores the need to integrate molecular testing into clinical practice and national guidelines to enable more targeted treatment and strengthen antimicrobial stewardship in the face of evolving AMR.

Further reading: Infect Drug Resist
Author(s): Ahmad R Alsayed et al
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!